Time-dependent kinetics III: diurnal oscillations in steady-state plasma valproic acid levels in rhesus monkeys.

Valproic acid was administered by constant rate intravenous infusion to catheterized chained rhesus monkeys for 8-10 weeks under controlled environmental conditions. Steady-state plasma levels were monitored at 2-hr intervals for 26 hr (10 am-12 noon on the following day), 1 day/week for 6 weeks. Individual steady-state plasma concentration-time plots exhibited the following characteristics. During Period A (10 am-6 pm), plasma levels remained stable or decreased. During Period B (6 pm-6 am), plasma levels increased, reached a maximum, and remained markedly higher than during Period A. The maximum concentrations were 40-140% higher than the observed minimum concentrations. During Period C (6 am-noon), plasma levels tended to decline from the maximum concentrations achieved in Period B. In most cases, plasma concentrations at 10 am and 12 noon of the 2nd experimental day fell within 10% of their respective values on the previous day. The mean (+/- SD) periods obtained by cross-correlation analysis of individual plasma concentration-time plots were 30.7 (+/- 3.7) and 22.8 (+/- 3.6) hr for Animals 903 and 923, respectively. The corresponding mean (+/- SD) amplitudes were 27.3 (+/- 12.6) and 17.4 (+/- 2.3)%. A circadian rhythm in total body clearance was hypothesized, and its pharmacokinetic implications are discussed.

[1]  J. Lockard,et al.  Time-dependent kinetics II: Diurnal oscillations in steady-state plasma ethosuximide levels in rhesus monkeys. , 1977, Journal of pharmaceutical sciences.

[2]  T. Kuhara,et al.  Metabolism of branched medium chain length fatty acid. II--beta-oxidation of sodium dipropylacetate in rats. , 1974, Biomedical mass spectrometry.

[3]  I. Patel,et al.  Pharmacokinetic Properties of Ethosuximide in Monkeys. I. Single‐Dose Intravenous and Oral Administration , 1975, Epilepsia.

[4]  I. Patel,et al.  Pharmacokinetic Properties of Ethosuximide in Monkeys. II. Chronic Intravenous and Oral Administration , 1975, Epilepsia.

[5]  J. Lockard,et al.  Efficacy of Standard Anticonvulsants in Monkey Model with Spontaneous Motor Seizures , 1975, Epilepsia.

[6]  E. di Salle,et al.  Daily rhythmic variation and liver drug metabolism in rats. , 1971, Biochemical pharmacology.

[7]  R. F. Leonard,et al.  High-frequency oscillation of blood free fatty acid levels in man. , 1971, Journal of applied physiology.

[8]  A. Winterburn,et al.  Diurnal variation in sensitivity to and metabolism of barbiturate in the rat: lack of correlation between in vivo and in vitro findings. , 1970, European journal of pharmacology.

[9]  W. F. Bousquet,et al.  Daily rhythmic variation in hepatic drug metabolism in the rat and mouse. , 1968, The Journal of pharmacology and experimental therapeutics.

[10]  E. Vesell.  GENETIC AND ENVIRONMENTAL FACTORS AFFECTING HEXOBARBITAL METABOLISM IN MICE , 1968, Annals of the New York Academy of Sciences.

[11]  W. F. Bousquet,et al.  Circadian rhythm in hepatic drug metabolizing activity in the rat. , 1967, Life sciences.

[12]  J. Lockard,et al.  Behavioral experimental epilepsy in monkeys. I. Clinical seizure recording apparatus and initial data. , 1967, Electroencephalography and clinical neurophysiology.

[13]  A. Beckett,et al.  Rhythmic Urinary Excretion of Amphetamine in Man , 1964, Nature.